Modules

Share

Program Content

Activities

  • 1L Therapy
    Individualizing Frontline Therapy for Patients With Chronic Lymphocytic Leukemia: Putting Evidence Into Practice
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 19, 2022

    Expires: April 18, 2023

  • AEs With BCL-2i/PI3Ki
    Multidisciplinary Perspectives on Managing Adverse Events With BCL-2 and PI3K Inhibitors in CLL
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 19, 2022

    Expires: May 18, 2023

  • AEs With BTKis
    Multidisciplinary Perspectives on CLL-Related Symptoms and Managing Adverse Events With BTK Inhibitors
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 31, 2022

    Expires: May 30, 2023

  • Patient CLL Concerns
    Addressing Patient Knowledge Gaps, Concerns, and Misperceptions About CLL
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 17, 2022

    Expires: August 16, 2023

  • MRD in CLL
    Assessing Measurable Residual Disease in Chronic Lymphocytic Leukemia
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 30, 2022

    Expires: August 29, 2023

  • CLL Treatment Evolution
    Evolving CLL Treatment Recommendations
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 06, 2022

    Expires: October 05, 2023

Faculty

cover img faculity

Nichole Fisher, RN, BSN

Clinical Research Supervisor
Willamette Valley Cancer Institute
Eugene, Oregon

cover img faculity

Brian Koffman, MDCM

PCN Content Reviewer
Medical Director, CLL Society Inc.
Partner, St Jude Heritage Medical Group
Diamond Bar, California
Clinical Professor (Retired)
Department of Family Medicine
Keck School of Medicine, USC Family Practice
Los Angeles, California

cover img faculity

Nicole Lamanna, MD

Associate Professor
Leukemia Service
Director of CLL Program
Hematologic Malignancies Section
Department of Medicine
New York-Presbyterian/Columbia University Medical Center
New York, New York

cover img faculity

Anthony J. Perissinotti, PharmD, BCOP

Hematology Clinical Pharmacist Specialist
University of Michigan
Ann Arbor, Michigan

cover img faculity

Jennifer A. Woyach, MD

D. Warren Brown Professor of Leukemia Research
Division of Hematology
The Ohio State University
Columbus, Ohio

Provided by

ProCE Banner

Supporters

AbbVie Inc.

AstraZeneca

Eli Lilly

Janssen Biotech

Pharmacyclics an AbbVie Company

TG Therapeutics

Partners

CLL Society

ProCE Banner